Dyad
Dyad (Dyad AI, Inc.) is a healthcare AI company whose ALIS DX platform, powered by its proprietary GENIE technology, converts unstructured clinical documents into standardized medical codes and quality insights for payers, providers, ACOs, and now insurance intermediaries.
- Company typePrivate
- Founded2020
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Dyad does
Dyad (legally Dyad AI, Inc.) is a healthcare-focused AI company that builds clinical document and data intelligence software for healthcare payers, providers, and accountable care organizations (ACOs). Its core platform, ALIS DX, transforms unstructured clinical text into structured SNOMED, ICD-10, and CPT codes and uses the resulting structured data to calculate quality measures (HEDIS, MIPS, eCQMs), close care gaps, support Star Ratings improvement, and improve coder throughput. The platform is powered by a proprietary technology called GENIE (Graph Enabled Information Extraction), which combines natural language processing with a clinical knowledge graph to handle complex outpatient coding without hallucination, with outputs delivered directly into customers' existing EHRs, applications, and data lakes.
The company operates a subscription-based, enterprise SaaS model with quote-based pricing and an annual billing cadence, selling through a direct consultative sales motion that funnels prospects into demo bookings. Its named flagship deployment is the BetterLetter application, powered by Dyad, which codes and workflows millions of pieces of NHS clinical correspondence per year across hundreds of UK primary care clinics. In November 2025, Dyad extended ALIS DX with an Email Triage Agent and Extractor module targeting insurance intermediaries (MGAs, wholesalers, and program admins), signaling a deliberate horizontalization of its document intelligence capabilities beyond pure clinical coding.
Dyad was founded in 2020 and is headquartered in London, United Kingdom, while its legal entity is incorporated in the United States. The company maintains HIPAA, SOC2 Type 2, and Cyber Essentials Plus certifications, positioning it for both US payer/provider sales and UK public-sector healthcare procurement. Funding to date totals approximately $4 million across 2020-2021 from Plug and Play, Carbide Ventures, Pantera Capital, and Sangha Capital, with no subsequent priced rounds disclosed in the source material.
Dyad firmographics
Firmographics- Name
- Dyad
- Legal name
- Dyad AI, Inc.
- Website
- https://dyad.net
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Dyad (Dyad AI, Inc.) is a healthcare AI company whose ALIS DX platform, powered by its proprietary GENIE technology, converts unstructured clinical documents into standardized medical codes and quality insights for payers, providers, ACOs, and now insurance intermediaries.
- Ownership category
- akta.pro rank
Dyad industry classification
Industry- Product category
- Healthcare AI / Clinical Document Intelligence
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Electronic Data Capture (EDC) Platforms (HLACAOAA)
- akta.pro secondary industry
- DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA) (HLACANAN)
Keywords
Where Dyad is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Dyad business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Revenue model
- Healthcare AI Platform Subscription: SaaS platform subscription model providing AI-powered clinical document intelligence to healthcare payers, providers, and ACOs. The ALIS DX platform embeds AI capabilities directly into existing workflows, with pricing likely tiered by volume or functionality.
- ALIS DX Platform Licensing: Licensing of ALIS DX platform featuring AI capabilities for email and document processing, targeting MGAs, wholesalers, and program administrators in the insurance space.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Quote-based enterprise pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
Dyad product offering
Product offeringCore offering
Dyad sells the ALIS DX platform, an AI-powered clinical document and data intelligence solution that uses its proprietary GENIE technology to extract medical entities from unstructured clinical documents and output structured SNOMED, ICD-10, and CPT codes. The platform delivers real-time quality measurement, Star ratings improvement, care gap closure, RADV readiness, and coder productivity tools to healthcare payers, providers, ACOs, and insurance intermediaries.
Product overview
Dyad offers a unified AI-powered platform called ALIS DX for clinical document and data intelligence in healthcare. The platform is powered by the proprietary GENIE (Graph Enabled Information Extraction) technology, which combines graph-based knowledge representation with natural language processing to extract and code clinical data from unstructured documents. ALIS DX serves payers, providers, and ACOs through modules including real-time quality measurement (HEDIS, MIPS, eCQMs), Star ratings optimization, care gap closure, RADV readiness, and coder productivity tools. The Email Triage Agent and Extractor module extends the platform's capabilities to insurance intermediaries for automated email and document processing.
Differentiator
Problem solved
Functional benefit
Brands
- ALIS DX: AI platform with email and document processing capabilities for MGAs, wholesalers, and program admins, featuring Email Triage Agent and Extractor
- GENIE
- BetterLetter
Products and services
- ALIS DX AI-powered clinical document and data intelligence platform that transforms unstructured healthcare data into structured SNOMED, ICD-10, and CPT codes, enabling real-time quality measurement (HEDIS, MIPS, eCQMs), Star ratings improvement, care gap closure, RADV readiness, and coder productivity for healthcare payers, providers, ACOs, and insurance intermediaries.
- Email Triage Agent and Extractor AI-powered module within ALIS DX that automates email triage and document extraction for insurance intermediaries (MGAs, wholesalers, program administrators), improving processing accuracy and reducing response times.
Quantifiable outcome
- Dramatically reduced manual chart review
- +2 more outcomes
Companies that use Dyad
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles5 records
Dyad technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature6 records
Dyad partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- BetterLettercoreBetterLetter is an application powered by Dyad's AI technology, used by hundreds of NHS primary care clinics to code and workflow millions of pieces of clinical correspondence per year. This represents a technology partnership where Dyad provides the underlying AI platform for clinical document intelligence.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
Dyad competitors and assessment
Company assessmentBroad incumbents
- Nuance Communications (Microsoft): Acquired by Microsoft, Nuance provides Dragon Medical One and DAX Copilot — clinical NLP and ambient documentation AI for healthcare providers. Overlaps with Dyad's clinical document intelligence and EHR-integrated AI workflows.
- Optum (UnitedHealth Group): Optum offers risk adjustment, HEDIS/Star quality measurement and clinical analytics at massive scale for payers and providers. Directly comparable to Dyad's quality-measurement and RADV/HEDIS use cases, but at incumbent scale.
- Amazon Comprehend Medical: AWS-managed NLP service extracting medical entities and codes from unstructured clinical text. Directly comparable to GENIE's core NLP capability but offered as a commoditized cloud API rather than a healthcare-specialized SaaS platform.
Emerging players
- AKASA: AI platform for healthcare revenue cycle management automating authorization, coding and billing workflows for providers. Comparable to Dyad in targeting healthcare administrative automation with AI-driven document processing.
- Notable: AI platform automating hospital operations including patient intake, scheduling and clinical documentation. Comparable to Dyad in applying AI to healthcare administrative workflows and EHR-integrated process automation.
- Cohere Health: AI-driven prior authorization and clinical intelligence platform for payers and providers. Comparable to Dyad in using AI/NLP to streamline payer-provider workflows and reduce administrative friction in healthcare.
- Suki AI: AI voice assistant for clinicians that automates clinical documentation and integrates with EHRs. Comparable to Dyad in using AI to reduce clinician documentation burden and produce structured clinical output.
Direct peers
- 3M Health Information Systems (Solventum): Spun off from 3M in 2024, Solventum (formerly 3M HIS) is a dominant clinical coding and health information systems vendor offering computer-assisted coding, NLP and revenue cycle solutions — directly comparable to Dyad's GENIE-based clinical coding platform for providers and payers.
- Innovaccer: Healthcare data activation platform unifying clinical, claims and social data for payers, providers and ACOs. Comparable to Dyad in building a structured data layer to enable quality measurement, care gap closure and value-based care analytics.
Regional players
- Waystar: Healthcare revenue cycle management platform including coding, claims and analytics for US providers. Comparable to Dyad's administrative automation and clinical data integrity use cases, primarily serving the US market with broader RCM scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Dyad social profiles
Digital presenceDyad compliance and trust
Trust signalCompliance3 records
Dyad financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dyad leadership team
Management profileNumber of profiles
Profiles1 record
Dyad funding detail
Funding detailFunding overview
Funding rounds4 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dyad M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dyad
What does Dyad do?
Dyad sells the ALIS DX platform, an AI-powered clinical document and data intelligence solution that uses its proprietary GENIE technology to extract medical entities from unstructured clinical documents and output structured SNOMED, ICD-10, and CPT codes. The platform delivers real-time quality measurement, Star ratings improvement, care gap closure, RADV readiness, and coder productivity tools to healthcare payers, providers, ACOs, and insurance intermediaries.
Is Dyad a public or private company?
Dyad is a private company. It is classified as venture growth investor backed and is currently operating.
When was Dyad founded?
Dyad was founded in 2020. It employs 1 to 10 people.
Where is Dyad based?
Dyad is headquartered in London, United Kingdom, in the Europe region.
How does Dyad make money?
Two revenue lines are on record. Healthcare AI Platform Subscription is the primary driver. The others are ALIS DX Platform Licensing.
Who are Dyad's main competitors?
Broad incumbents on record are Nuance Communications (Microsoft), Optum (UnitedHealth Group) and Amazon Comprehend Medical. Emerging players are AKASA, Notable, Cohere Health and Suki AI. Direct peers are 3M Health Information Systems (Solventum) and Innovaccer. Waystar is listed as a regional player.
Does Dyad have an API?
No public API is recorded for Dyad.
What industry is Dyad in?
Dyad's product category is Healthcare AI / Clinical Document Intelligence. Its primary akta.pro industry code is HLACAOAA, Electronic Data Capture (EDC) Platforms, with a secondary code of HLACANAN, DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA). Its NAICS code is 5132 and its SIC code is 7372.